SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

REC Ltd

Industry : Finance - Term-Lending Institutions

BSE Code

ISIN Demat

Book Value()

532955

INE020B01018

314.2114154

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RECLTD

4.98

85355.96

EPS(TTM)

Face Value()

Div & Yield %

65.15

5.55

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)